Cooper Companies (COO) Shares Outstanding (Diluted Average) (2009 - 2026)
Cooper Companies (COO) recorded quarterly Shares Outstanding (Diluted Average) of $195.0 million in Q2 2026, down 0.86% quarter-over-quarter from $196.7 million in Q1 2026, and down 2.84% year-on-year from $200.7 million in Q2 2025.
Cooper Companies (COO) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Shares Outstanding (Diluted Average) across 18 years of filings, most recently posting $195.0 million for Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Diluted Average) fell 2.84% year-over-year to $195.0 million; the trailing twelve-month figure through Apr 2026 stood at $195.0 million (down 2.84% YoY), and the FY2025 full-year result was $200.0 million, changed 0.2% from the prior year.
- Shares Outstanding (Diluted Average) was $195.0 million for Q2 2026 at Cooper Companies, down from $196.7 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $201.2 million in Q1 2025 and troughed at $49.7 million in Q3 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $199.2 million (2023), against an average of $174.4 million.
- The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Diluted Average) soared 300.8% in 2023, then decreased 2.84% in 2026.
- Year by year, Shares Outstanding (Diluted Average) stood at $198.8 million in 2022, then advanced by 0.25% to $199.3 million in 2023, then rose by 0.55% to $200.4 million in 2024, then declined by 0.2% to $200.0 million in 2025, then fell by 2.5% to $195.0 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Diluted Average) figures were $195.0 million in Q2 2026, $196.7 million in Q1 2026, and $200.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 64.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 195.00 Mn |
| Jan 31, 2026 | 196.70 Mn |
| Oct 31, 2025 | 200.00 Mn |
| Jul 31, 2025 | 200.60 Mn |
| Apr 30, 2025 | 200.70 Mn |
| Jan 31, 2025 | 201.20 Mn |
| Oct 31, 2024 | 200.40 Mn |
| Jul 31, 2024 | 200.60 Mn |
| Apr 30, 2024 | 200.20 Mn |
| Jan 31, 2024 | 199.90 Mn |
| Oct 31, 2023 | 199.30 Mn |
| Jul 31, 2023 | 199.20 Mn |
| Apr 30, 2023 | 199.20 Mn |
| Jan 31, 2023 | 198.70 Mn |
| Oct 31, 2022 | 198.80 Mn |
| Jul 31, 2022 | 49.70 Mn |
| Apr 30, 2022 | 49.80 Mn |
| Jan 31, 2022 | 49.90 Mn |
| Oct 31, 2021 | 49.80 Mn |
| Jul 31, 2021 | 49.70 Mn |